mMe: Motivational Monitoring to Enhance Smoking Cessation Among Cancer Patients

Completed

• Conditions: Cancer; Smoking Behaviors; Motivation
• Interventions: Other: There is no intervention for this study

• Registration Number: NCT05370859
• Lead Sponsor: University of Virginia

Brief Summary

The objectives of this study are to pilot test a protocol of weekly assessments of motivation to quit and other relevant constructs combined with information about how to enroll in cessation programs, which will allow initial quantification of motivation to quit during cancer treatment and develop hypotheses about the impact of motivation on the decision to enroll in services.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-04-27
• Study First Submitted QC: 2022-05-06
• Study First Posted: 2022-05-12
• Study Start: 2022-07-18
• Primary Completion: 2024-02-13
• Study Completion: 2024-02-13
• Status Verified: 2024-04
• Last Update Submitted: 2024-04-01
• Last Update Posted: 2024-04-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• An adult (18+)
• Current smoker defined by: Has smoked 100 cigarettes in their lifetime (may be multi-tobacco users as long as they also use combustible cigarettes).
• Any type of cancer (except non-melanoma skin cancer)
• Anticipates receiving any of the following cancer treatments in the 3 months following enrollment: chemotherapy, surgery, immunotherapy, bone marrow or stem cell transplant, hormone therapy, or radiation
• Access to the Internet

Exclusion Criteria

• Not smoked 100 cigarettes in their lifetime
• < 18 years in age
• Diagnosed with non-melanoma skin cancer
• Not diagnosed with cancer
• Does not anticipate receiving cancer treatments in the 3 months following enrollment
• Has been previously enrolled in an existing Cancer Center Tobacco Treatment Program (TTP)
• Not comfortable reading and responding to questions in English
• No consistent access to the Internet

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Mme Study Participants	There is no intervention for this study	Participants will complete a baseline survey, 11 weekly surveys, and a follow-up survey at 12 weeks

Primary Outcome Measures

Name	Time	Method
Number of participants who enroll in cessation services	12 weeks after study start	Assessed using administrative records

Secondary Outcome Measures

Name	Time	Method
Number of smoking quit attempts	12 weeks after study start	Assessed using self-report on the weekly and 12-week survey
Level of and change in motivation and self-efficacy to quit smoking	Through study completion, an average of 12 weeks	Assessed using self-report on the weekly and 12-week survey
Level of and change in anxiety and depression	Through study completion, an average of 12 weeks	Assessed using self-report (PHQ-4) on the weekly and 12-week survey

Trial Locations

Locations (1)

University of Virginia Cancer Center and affiliated sites; 🇺🇸 Charlottesville, Virginia, United States